Kirtland Hills Capital Management’s Boston Scientific BSX Stock Holding History

Kirtland Hills Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$416K	Sell	9,744 -56	-0.6%	-$3.04K	0.12%	135
2026 Q1	$633K	Sell	9,800 -639	-6%	-$51.1K	0.2%	106
2025 Q4	$995K	Hold	10,439	–	–	0.35%	76
2025 Q3	$1.02M	Sell	10,439 -65	-0.6%	-$6.73K	0.4%	70
2025 Q2	$1.13M	Hold	10,504	–	–	0.52%	62
2025 Q1	$999K	Buy	10,504 +261	+3%	+$26.3K	0.61%	53
2024 Q4	$915K	Buy	10,243 +266	+3%	+$23.4K	0.59%	61
2024 Q3	$836K	Hold	9,977	–	–	0.46%	64
2024 Q2	$768K	Hold	9,977	–	–	0.64%	57
2024 Q1	$729K	Buy	+9,977	New	+$641K	0.63%	58

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kirtland Hills Capital Management's BSX Position: Q2 2026 in Review

Kirtland Hills Capital Management reduced its Boston Scientific (BSX) stake by 0.57% in Q2 2026, selling an estimated $3.04K and leaving 9,744 shares worth $416K. The position accounts for 0.12% of the portfolio, ranked #135.

Kirtland Hills Capital Management first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.13M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Kirtland Hills Capital Management held 9,744 shares of Boston Scientific worth $416K as of Q2 2026.
Kirtland Hills Capital Management sold 56 Boston Scientific shares in Q2 2026, an estimated $3.04K.
Boston Scientific made up 0.12% of Kirtland Hills Capital Management's portfolio in Q2 2026, its #135 holding.
Kirtland Hills Capital Management first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
Kirtland Hills Capital Management's Boston Scientific position peaked at $1.13M in Q2 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.